Literature DB >> 22707180

A qualitative study to explore psychological distress and illness burden associated with opioid-induced constipation in cancer patients with advanced disease.

Lara Dhingra1, Elyse Shuk, Bella Grossman, Alessandra Strada, Emily Wald, Allison Portenoy, Helena Knotkova, Russell Portenoy.   

Abstract

BACKGROUND: Constipation affects many patients receiving long-term opioid therapy for cancer pain. Little is known about the nature of psychological distress and the burden associated with this problem. This information may inform the development of effective treatment strategies and ameliorate distress. AIM: The objective was to use qualitative research methods to better understand psychological distress and the burden associated with opioid-induced constipation and its treatment in advanced cancer patients.
DESIGN: In this qualitative study, semi-structured interviews explored perceptions of psychological distress and burden from opioid-induced constipation. Interviews were analyzed using a thematic content analysis approach involving descriptive and interpretive coding and identification of recurring themes. SETTING/PARTICIPANTS: Twelve advanced cancer patients with opioid-induced constipation were recruited from a large urban hospital.
RESULTS: Patients experienced various types of negative affect and cognitions associated with opioid-induced constipation. Analyses indicated three major themes: (1) irrational thoughts and educational needs; (2) psychological distress from constipation and (3) the effects of constipation on the decision to use opioid analgesics. Irrational thoughts and educational needs included beliefs that nutrition could improve constipation, the supposition that constipation indicated deteriorating health, and catastrophic beliefs. Psychological distress included depressive symptoms and anticipatory anxiety related to constipation. Decision-making revealed cognitive dissonance about using opioids and conflicting preferences about continuing use.
CONCLUSIONS: Future investigation of the multiple components of cognitive and affective burden from opioid-induced constipation is warranted. Understanding the varied nature of this burden may improve clinical recognition and assessment and promote more intensive management consistent with the distress it produces.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22707180     DOI: 10.1177/0269216312450358

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  13 in total

1.  Constipation in specialized palliative care: factors related to constipation when applying different definitions.

Authors:  E Erichsén; A Milberg; T Jaarsma; M Friedrichsen
Journal:  Support Care Cancer       Date:  2015-07-10       Impact factor: 3.603

2.  Prevalence of constipation in patients undergoing chemotherapy and the effect of constipation on quality of life.

Authors:  Zeynep Pehlivan; Nesrin Nural
Journal:  Support Care Cancer       Date:  2022-06-28       Impact factor: 3.359

3.  Symptom screening for constipation in oncology: getting to the bottom of the matter.

Authors:  Madeline Li; Caroline Sanders; Chieh-Hsin Lee; Bryan Gascon; Alyssa Macedo; Sean Molloy; Stephane Laframboise; Yvonne W Leung
Journal:  Support Care Cancer       Date:  2018-10-30       Impact factor: 3.603

Review 4.  MASCC recommendations on the management of constipation in patients with advanced cancer.

Authors:  Andrew Davies; Charlotte Leach; Ricardo Caponero; Andrew Dickman; David Fuchs; Judith Paice; Anton Emmanuel
Journal:  Support Care Cancer       Date:  2019-08-09       Impact factor: 3.603

5.  Patient preferences for change in symptoms associated with opioid-induced constipation.

Authors:  Robert S Epstein; Ali Cimen; Hannah Benenson; Ronald E Aubert; Mona Khalid; Mark B Sostek; Tehseen Salimi
Journal:  Adv Ther       Date:  2014-11-21       Impact factor: 3.845

Review 6.  Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.

Authors:  Roberto De Giorgio; Furio Massimino Zucco; Giuseppe Chiarioni; Sebastiano Mercadante; Enrico Stefano Corazziari; Augusto Caraceni; Patrizio Odetti; Raffaele Giusti; Franco Marinangeli; Carmine Pinto
Journal:  Adv Ther       Date:  2021-06-04       Impact factor: 3.845

7.  Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility.

Authors:  Richard Lawson; Frederic King; Kevin Marsh; Arman Altincatal; Ali Cimen
Journal:  Adv Ther       Date:  2016-06-24       Impact factor: 3.845

8.  Care interaction adding challenges to old patients' well-being during surgical hospital treatment.

Authors:  Lisbeth Uhrenfeldt; Mette Terp Høybye
Journal:  Int J Qual Stud Health Well-being       Date:  2015-10-23

9.  Gastrointestinal Motility and Improvement Efficacy of Shenhuang Plaster Application on Shenque: Identification, Evaluation, and Mechanism.

Authors:  Yanan Shi; Jingming Xu; Bin Ding; Guiping Chen; Lu Jin; Liang Ke; Xiao Xu; JingXia Wang; Qiuhua Sun; Xiaohong Xu
Journal:  J Immunol Res       Date:  2020-07-11       Impact factor: 4.818

10.  The Efficacy and Safety of Transcutaneous Acupoint Interferential Current Stimulation for Cancer Pain Patients With Opioid-Induced Constipation: A Prospective Randomized Controlled Study.

Authors:  Hua-Dong Zhu; Zhen Gong; Bing-Wei Hu; Qiao-Ling Wei; Jun Kong; Cong-Bin Peng
Journal:  Integr Cancer Ther       Date:  2017-10-27       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.